Breast Cancer Survival Rate Improved Using Targeted Therapy and Genetic Profiling

Breast cancer is one of the most common cancer in women in many countries and the peak age of occurrence is between 44 and 60 years old. New research found that breast cancer survival rate are being improved using targeted therapy and genetic profiling of tumors. An advancement in breast cancer treatment.

Such advancements consists of developments in radiotherapy, which have enabled this treatment selection to get more targeted and develop less side effects and the existence of new chemotherapy and hormonal drugs.

Radiotherapy is now more exact and these cuts down long term adverse effect on the surrounding organs. Betterment in chemotherapy permits formerly resistive tumors to be controlled. Having more chemotherapy options allows oncologist to use less older and more toxic chemotherapy drugs.

Study has indicated that advancements in medical technology have corresponded with improvement in breast cancer survival rates. The latest betterment in breast cancer treatment are targeted therapy and tumor genetic profiling.

Targeted therapy is a new type of cancer treatment which utilizes drugs or other compounds to home in on and attack cancer cells. Genetic profiling of tumor correspondences and deciphers the genetic data of tumors. Genetic profiling permits doctor to anticipate the behavior of the cancer, especially its ability to induce a relapse in future.

One example of how targeted therapy can be used to fight breast cancer is the artificially produced antibody trastuzumab, which could be used in both early and late stage breast cancer if the target that the antibody works on is present.
These drugs switch off the growth breast cancer cells, which forces cancer to grow and proliferate. Their added advantage is that they have minimal side effects.

Besides advancements in breast treatment, a change in doctors approach to breast cancer treatment which may have also encouraged breast cancer survival rates. There is a trend in doctors towards being more restrained or conservative use of surgery and being more aggressive use of chemotherapy, targeted therapy and hormonal therapy.

By channelizing effort towards better control of relapse in the rest of the body, the survival rates of with breast cancer has steadily improved. Now, when breast cancer is discovered at an earlier stage, it is not rare to be able to reach long-term survival in eight or nine out of 10 women.

Breast Cancer Radiation Treatments – Single Dose Treatment for Breast Cancer

A new Breast Cancer Radiation Treatments results were published in The Lancet medical journal indicating that single dose of radiation treatment for breast cancer during surgery is just as efficient for breast cancer patients compared to those receiving weeks of radiation.

Over 2,000 women from 9 countries in Europe, North America and Asia participated in the test, in which a one-time blast radiation or was directed at a tumor location during surgery. The test presented that four years after this single dose radiation treatment for breast cancer, the chances of having a recurrence of breast cancer was almost the same for both radiation treatments.

Applying the single dose procedure would be more convenient for patients and also greatly cut down the waiting lists. It is the next step in opening up a wider range of alternatives for women. These new treatment technique could save patients weeks of after operation radiotherapy that can lead to 20 or 30 visits to hospital. The single dose breast cancer radiation treatment during surgery also prevents possible harm from radiation exposure to organs such as the heart, lung, and oesophagus.

These new technique is called the Targets Intra-operative Radiotherapy, whereby a mobile radiotherapy machine is used to insert into the breast to direct the exact locate of the breast cancer. However, the major drawback is that while the study followed women for four years after their cancer was diagnosed, the disease can sometimes recur after eight or more years. Also, the findings were only applicable to women with a same type of breast cancer as those in the test but still researchers were excited about the findings.

Radiotherapy is already a very effective treatment, so improving it even further is an exciting prospect. Additional follow-up on these women will be required to affirm whether this breast cancer radiation treatment is not only makes the most of the therapy’s power but also reduces any long-term side effects.